Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
343 studies found for:    "Hypopharyngeal cancer"
Show Display Options
RSS Create an RSS feed from your search for:
"Hypopharyngeal cancer"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer
Conditions: Hypopharyngeal Carcinoma;   Laryngeal Carcinoma
Intervention: Other: Pharyngo laryngeal MRI
2 Recruiting Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
Conditions: Oropharyngeal Cancer;   Hypopharyngeal Cancer
Interventions: Drug: docetaxel and cisplatin;   Radiation: IMRT;   Biological: Nimotuzumab
3 Active, not recruiting Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
Condition: Hypopharyngeal Cancer
Interventions: Drug: neoadjuvant docetaxel/cisplatin/fluorouracil;   Drug: No treatment before definitive CCRT
4 Unknown  The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Conditions: Laryngeal Cancer;   Hypopharyngeal Cancer
5 Terminated SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
Condition: Head and Neck Cancer
Interventions: Drug: Induction chemotherapy;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: low-LET cobalt-60 gamma ray therapy
6 Unknown  The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Conditions: Laryngeal Cancer;   Hypopharyngeal Cancer;   Metastasis
7 Completed Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma
Conditions: Larynx Cancer;   Hypopharynx Cancer
Intervention: Drug: DOCETAXEL
8 Completed Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
Conditions: Larynx Cancer;   Hypopharynx Cancer
Interventions: Drug: cetuximab;   Drug: Cisplatin;   Procedure: Radiotherapy 70 Gy, 35 fractions
9 Recruiting A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients
Conditions: Laryngeal Cancer;   Hypopharynx Cancer
Intervention: Device: Modified Trans-Esophageal Prosthesis
10 Terminated Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer
Conditions: Oropharynx Cancer;   Hypopharynx Cancer
Interventions: Drug: Homeodent®;   Drug: 1.4% Sodium Bicarbonate solution
11 Active, not recruiting A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
Conditions: Oropharyngeal Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer
Intervention: Drug: Cetuximab
12 Unknown  The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis
Conditions: Oral Cancer;   Laryngeal Cancer;   Hypopharyngeal Cancer
13 Unknown  Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
Conditions: Head and Neck Cancer;   Radiation Toxicity;   Xerostomia
Interventions: Procedure: management of therapy complications;   Radiation: radiation therapy
14 Completed Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx
Condition: Head and Neck Cancer
Interventions: Drug: docetaxel;   Radiation: radiation therapy
15 Withdrawn Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence
Condition: Head and Neck Cancer
Interventions: Biological: panitumumab;   Drug: cisplatin;   Drug: fluorouracil;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: quality-of-life assessment;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
16 Completed Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)
Conditions: Squamous Cell Carcinoma of the Hypopharynx;   Larynx Carcinoma
Interventions: Radiation: Radiation;   Drug: Cetuximab;   Drug: Docetaxel;   Drug: Cisplatin (TP);   Drug: 5-Fluorouracil (TPF) (only until Feb 2009)
17 Active, not recruiting IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
Conditions: Oral Cancer;   Oropharynx Cancer;   Hypopharynx Cancer
Interventions: Procedure: IMRT 75 Gy;   Procedure: Conventional radiotherapy 70 Gy;   Drug: concomitant cisplatin
18 Terminated Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers
Condition: Larynx Neoplasms
Interventions: Radiation: Concurrent Chemoradiation;   Procedure: Laryngectomy + adjuvant radiotherapy/chemoradiotherapy
19 Completed Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
Condition: Head and Neck Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
20 Completed
Has Results
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery
Conditions: Head and Neck Cancer;   Oropharyngeal Cancer;   Hypopharyngeal Cancer;   Upper Aerodigestive Tract Neoplasms
Intervention: Procedure: da Vinci® Robotic System

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.